# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Talarozole | TALAROZOLE | IC50 relative | = | 14400 | nM | ALA5303715 | Inactive | nM | Homo sapiens | ||
2. | Talarozole | TALAROZOLE | IC50 relative | 0 | ALA5303712 | Inactive | Severe acute respiratory syndrome coronavirus 2 | |||||
3. | Talarozole | TALAROZOLE | inhibition | = | 0.34 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
4. | Talarozole | TALAROZOLE | inhibition | = | 22.29 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
5. | Talarozole | TALAROZOLE | Inhibition | = | 20.952 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
6. | Talarozole | TALAROZOLE | Inhibition | = | -0.02 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
7. | Talarozole | TALAROZOLE | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
8. | Talarozole | TALAROZOLE | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
9. | Talarozole | TALAROZOLE | inhibition | = | 0.34 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
10. | Talarozole | TALAROZOLE | inhibition | = | 22.29 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
11. | Talarozole | TALAROZOLE | inhibition | = | 23.24 | % | ALA4808150 | % | Homo sapiens | |||
12. | Talarozole | TALAROZOLE | inhibition | = | 11.88 | % | ALA4808149 | % | Homo sapiens | |||
13. | Talarozole | TALAROZOLE | Inhibition | = | 47.05 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
14. | Talarozole | TALAROZOLE | IC50 | = | 0.005 | uM | ALA3789264 | 8.29 | nM | Homo sapiens | ||
15. | Talarozole | TALAROZOLE | IC50 | = | 0 | uM | ALA3789263 | 9.34 | nM | Homo sapiens |